[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Biotechnology-South America Market Status and Trend Report 2013-2023

March 2018 | 132 pages | ID: B6955729E99MEN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Biotechnology-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biotechnology industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole South America and Regional Market Size of Biotechnology 2013-2017, and development forecast 2018-2023
Main market players of Biotechnology in South America, with company and product introduction, position in the Biotechnology market
Market status and development trend of Biotechnology by types and applications
Cost and profit status of Biotechnology, and marketing status
Market growth drivers and challenges

The report segments the South America Biotechnology market as:

South America Biotechnology Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Brazil
Argentina
Venezuela
Colombia
Others

South America Biotechnology Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DNA Sequencing
Nanobiotechnology
Tissue engineering and Regeneration
Fermentation
Cell Based Assay
PCR Technology
Chromatography Market
Others

South America Biotechnology Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Health
Food & Agriculture
Natural Resources & Environment
Industrial Processing
Bioinformatics
Others

South America Biotechnology Market: Players Segment Analysis (Company and Product introduction, Biotechnology Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson Services, Inc.
F. Hoffmann-La Roche Ltd
Pfizer
Merck & Co.
Sanofi
AstraZeneca
Gilead
CELGENE CORPORATION
Biogen
Amgen, Inc
Abbott
Novo Nordisk A/S
Novartis AG
Lonza

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BIOTECHNOLOGY

1.1 Definition of Biotechnology in This Report
1.2 Commercial Types of Biotechnology
  1.2.1 DNA Sequencing
  1.2.2 Nanobiotechnology
  1.2.3 Tissue engineering and Regeneration
  1.2.4 Fermentation
  1.2.5 Cell Based Assay
  1.2.6 PCR Technology
  1.2.7 Chromatography Market
  1.2.8 Others
1.3 Downstream Application of Biotechnology
  1.3.1 Health
  1.3.2 Food & Agriculture
  1.3.3 Natural Resources & Environment
  1.3.4 Industrial Processing
  1.3.5 Bioinformatics
  1.3.6 Others
1.4 Development History of Biotechnology
1.5 Market Status and Trend of Biotechnology 2013-2023
  1.5.1 South America Biotechnology Market Status and Trend 2013-2023
  1.5.2 Regional Biotechnology Market Status and Trend 2013-2023

CHAPTER 2 SOUTH AMERICA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Biotechnology in South America 2013-2017
2.2 Consumption Market of Biotechnology in South America by Regions
  2.2.1 Consumption Volume of Biotechnology in South America by Regions
  2.2.2 Revenue of Biotechnology in South America by Regions
2.3 Market Analysis of Biotechnology in South America by Regions
  2.3.1 Market Analysis of Biotechnology in Brazil 2013-2017
  2.3.2 Market Analysis of Biotechnology in Argentina 2013-2017
  2.3.3 Market Analysis of Biotechnology in Venezuela 2013-2017
  2.3.4 Market Analysis of Biotechnology in Colombia 2013-2017
  2.3.5 Market Analysis of Biotechnology in Others 2013-2017
2.4 Market Development Forecast of Biotechnology in South America 2018-2023
  2.4.1 Market Development Forecast of Biotechnology in South America 2018-2023
  2.4.2 Market Development Forecast of Biotechnology by Regions 2018-2023

CHAPTER 3 SOUTH AMERICA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole South America Market Status by Types
  3.1.1 Consumption Volume of Biotechnology in South America by Types
  3.1.2 Revenue of Biotechnology in South America by Types
3.2 South America Market Status by Types in Major Countries
  3.2.1 Market Status by Types in Brazil
  3.2.2 Market Status by Types in Argentina
  3.2.3 Market Status by Types in Venezuela
  3.2.4 Market Status by Types in Colombia
  3.2.5 Market Status by Types in Others
3.3 Market Forecast of Biotechnology in South America by Types

CHAPTER 4 SOUTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Biotechnology in South America by Downstream Industry
4.2 Demand Volume of Biotechnology by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Biotechnology by Downstream Industry in Brazil
  4.2.2 Demand Volume of Biotechnology by Downstream Industry in Argentina
  4.2.3 Demand Volume of Biotechnology by Downstream Industry in Venezuela
  4.2.4 Demand Volume of Biotechnology by Downstream Industry in Colombia
  4.2.5 Demand Volume of Biotechnology by Downstream Industry in Others
4.3 Market Forecast of Biotechnology in South America by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIOTECHNOLOGY

5.1 South America Economy Situation and Trend Overview
5.2 Biotechnology Downstream Industry Situation and Trend Overview

CHAPTER 6 BIOTECHNOLOGY MARKET COMPETITION STATUS BY MAJOR PLAYERS IN SOUTH AMERICA

6.1 Sales Volume of Biotechnology in South America by Major Players
6.2 Revenue of Biotechnology in South America by Major Players
6.3 Basic Information of Biotechnology by Major Players
  6.3.1 Headquarters Location and Established Time of Biotechnology Major Players
  6.3.2 Employees and Revenue Level of Biotechnology Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 BIOTECHNOLOGY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Johnson & Johnson Services, Inc.
  7.1.1 Company profile
  7.1.2 Representative Biotechnology Product
  7.1.3 Biotechnology Sales, Revenue, Price and Gross Margin of Johnson & Johnson Services, Inc.
7.2 F. Hoffmann-La Roche Ltd
  7.2.1 Company profile
  7.2.2 Representative Biotechnology Product
  7.2.3 Biotechnology Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd
7.3 Pfizer
  7.3.1 Company profile
  7.3.2 Representative Biotechnology Product
  7.3.3 Biotechnology Sales, Revenue, Price and Gross Margin of Pfizer
7.4 Merck & Co.
  7.4.1 Company profile
  7.4.2 Representative Biotechnology Product
  7.4.3 Biotechnology Sales, Revenue, Price and Gross Margin of Merck & Co.
7.5 Sanofi
  7.5.1 Company profile
  7.5.2 Representative Biotechnology Product
  7.5.3 Biotechnology Sales, Revenue, Price and Gross Margin of Sanofi
7.6 AstraZeneca
  7.6.1 Company profile
  7.6.2 Representative Biotechnology Product
  7.6.3 Biotechnology Sales, Revenue, Price and Gross Margin of AstraZeneca
7.7 Gilead
  7.7.1 Company profile
  7.7.2 Representative Biotechnology Product
  7.7.3 Biotechnology Sales, Revenue, Price and Gross Margin of Gilead
7.8 CELGENE CORPORATION
  7.8.1 Company profile
  7.8.2 Representative Biotechnology Product
  7.8.3 Biotechnology Sales, Revenue, Price and Gross Margin of CELGENE CORPORATION
7.9 Biogen
  7.9.1 Company profile
  7.9.2 Representative Biotechnology Product
  7.9.3 Biotechnology Sales, Revenue, Price and Gross Margin of Biogen
7.10 Amgen, Inc
  7.10.1 Company profile
  7.10.2 Representative Biotechnology Product
  7.10.3 Biotechnology Sales, Revenue, Price and Gross Margin of Amgen, Inc
7.11 Abbott
  7.11.1 Company profile
  7.11.2 Representative Biotechnology Product
  7.11.3 Biotechnology Sales, Revenue, Price and Gross Margin of Abbott
7.12 Novo Nordisk A/S
  7.12.1 Company profile
  7.12.2 Representative Biotechnology Product
  7.12.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S
7.13 Novartis AG
  7.13.1 Company profile
  7.13.2 Representative Biotechnology Product
  7.13.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novartis AG
7.14 Lonza
  7.14.1 Company profile
  7.14.2 Representative Biotechnology Product
  7.14.3 Biotechnology Sales, Revenue, Price and Gross Margin of Lonza

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOTECHNOLOGY

8.1 Industry Chain of Biotechnology
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIOTECHNOLOGY

9.1 Cost Structure Analysis of Biotechnology
9.2 Raw Materials Cost Analysis of Biotechnology
9.3 Labor Cost Analysis of Biotechnology
9.4 Manufacturing Expenses Analysis of Biotechnology

CHAPTER 10 MARKETING STATUS ANALYSIS OF BIOTECHNOLOGY

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications